Advertisement
Advertisement

TMO

TMO logo

Thermo Fisher Scientific, Inc.

608.18
USD
Sponsored
-15.73
-2.52%
Jan 28, 15:59 UTC -5
Closed
exchange

After-Market

609.00

+0.82
+0.13%

TMO Earnings Reports

Positive Surprise Ratio

TMO beat 33 of 39 last estimates.

85%

Next Report

Today BMO
Date of Next Report
Jan 29, 2026
Estimate for Q4 25 (Revenue/ EPS)
$12.07B
/
$6.51
Implied change from Q3 25 (Revenue/ EPS)
+8.52%
/
+12.44%
Implied change from Q4 24 (Revenue/ EPS)
+5.92%
/
+6.72%

Thermo Fisher Scientific, Inc. earnings per share and revenue

On Oct 22, 2025, TMO reported earnings of 5.79 USD per share (EPS) for Q3 25, beating the estimate of 5.54 USD, resulting in a 4.37% surprise. Revenue reached 11.12 billion, compared to an expected 11.02 billion, with a 0.96% difference. The market reacted with a +1.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analysts forecast an EPS of 6.51 USD, with revenue projected to reach 12.07 billion USD, implying an increase of 12.44% EPS, and increase of 8.52% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
FAQ
For Q3 2025, Thermo Fisher Scientific, Inc. reported EPS of $5.79, beating estimates by 4.37%, and revenue of $11.12B, 0.96% above expectations.
The stock price moved up 1.65%, changed from $557.99 before the earnings release to $567.20 the day after.
The next earning report is scheduled for Jan 29, 2026.
Based on 22 analysts, Thermo Fisher Scientific, Inc. is expected to report EPS of $6.51 and revenue of $12.07B for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement